School of Medicine
Showing 2,721-2,740 of 12,884 Results
-
Milana V. Dolezal, MD, MSci
Clinical Associate Professor, Medicine - Oncology
BioDr. Dolezal is a board-certified hematologist-oncologist with Stanford Medicine Cancer Center in Emeryville and a clinical associate professor in the Stanford School of Medicine, Division of Oncology.
She strives to work with patients to develop care plans that are comprehensive and personalized achieve the best possible outcomes and quality of life.
Dr. Dolezal also has extensive experience in research and drug development. She previously held positions as a clinical scientist, assistant medical director, and associate medical director in the BioOncology Therapeutics unit of the biotechnology company Genentech.
She has conducted clinical research into fertility preservation in patients with breast cancer, advanced treatments for triple-negative breast cancer, and patients’ adherence to anti-cancer therapy. She has co-authored articles on her research findings that appeared in the Journal of Clinical Oncology, Cancer, and other peer-reviewed publications.
She also co-authored the chapter “Progression from Hormone-Dependent to Hormone-Independent Breast Cancer” in the textbook Hormones, Genes and Cancer published by Oxford University Press.
Dr. Dolezal has made presentations to her peers at meetings of the American Association for Cancer Research, American Society of Clinical Oncology, and European Cancer Organisation. -
Sheila Dolezal
Casual - Non-Exempt, Obstetrics & Gynecology
Current Role at StanfordDirector of Finance & Administration, Department of Obstatrics & Gynecology
-
Pablo Domizi, Ph.D.
Senior Research Scientist-Basic Life, Pediatrics - Hematology/Oncology
BioI am passionate about translational research and how single cell technologies could open up new avenues for better and more accurate predictive models. Currently, I am focus on integrating single cell RNA and protein expression data to develop models to predict patient at risk for Antigen Loss relapse after CAR T cells immunotherapy.
-
Joseph P. Donahue
Clinical Associate Professor, Orthopaedic Surgery
BioDr. Donahue is a Board Certified Orthopaedic Surgeon with Subspecialty Certification in Orthopaedic Sports Medicine. He is fellowship trained and specializes in Arthroscopic and Minimally Invasive Reconstructive Surgery of the Shoulder and Knee, and Sports Medicine.
Dr. Donahue received his undergraduate degree from Stanford University and his Doctor of Medicine from Columbia University College of Physicians and Surgeons. He completed his residency in Orthopedic Surgery at St. Luke’s-Roosevelt Hospital Center (NYC), Memorial Sloan-Kettering Cancer Center (NYC), and the Alfred I. duPont Institute (DE), and went on to a fellowship in Orthopedic Sports Medicine at the Stanford/SOAR Sports Medicine Fellowship Program.
Dr. Donahue’s interests include arthroscopic surgery of the shoulder and knee. He specializes in anterior cruciate ligament injuries, shoulder instability, and rotator cuff tears. He has done research on both shoulder instability and rotator cuff tears and has developed new techniques and medical devices for rotator cuff and all soft tissue repairs. He has started and actively serves on the medical advisory board for several surgical device companies and continues to design new surgical devices for arthroscopic procedures. He has authored several device patents and journal articles.
Dr. Donahue has been a member of the American Academy of Orthopedic Surgeons and a Diplomat of the American Board of Orthopedic Surgery. He is also member of the Arthroscopy Association of North America, the American Orthopedic Society of Sports Medicine, the California Orthopedic Association, The International Knee Society, the California Medical Association, and the Santa Clara Medical Society.
Dr. Donahue has served as the Program Director of the SOAR Orthopedic Sports Medicine Fellowship Program. He has served as the Director of Santa Clara University’s Sports Medicine Program and the Head Team Physician for all of Santa Clara University’s athletic teams, a team physician for the San Francisco 49ers, the San Francisco Giants, the Stanford Athletic Department, and many other area collegiate and high school teams. -
Julia Donahue
Senior Project Manager, Med/Stanford Center for Clinical Research
BioJulia Donahue is a Clinical Research Manager with the Stanford Center for Clinical Research (SCCR) at Stanford University. Julia has been working with SCCR since 2021. Her professional interests include Project Management, Digital Health, Study-Startup, Hospital-Based Research, and Decentralized Clinical Trials. She has extensive clinical trial experience in multiple fields, including but not limited to cardiology, dermatology, endocrinology, infectious diseases, psychiatry, and rheumatology.
Julia graduated with honors from McGill University in 2016, where her primary research interests were in neurodevelopmental disorders and autobiographical memory. -
Krista Donaldson
Casual - Non-Exempt, School of Medicine - MDRP'S - Biodesign Program
Current Role at StanfordDirector of Innovation to Impact, Byers Center for Biodesign
-
Sarah S. Donaldson, MD
Catharine and Howard Avery Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsCombined Modality Treatment of Cancer
Late Effects of Treatment
Genetic Effects of Cancer
Rhabdomyosarcoma
Hodgkins Disease
Pediatric Radiation Oncolgy
Pediatric Oncolgy
Breast Cancer
Conformal Radiotherapy/IMRT
Radiotherapy for Benign Diseases -
Chunyang Dong
Postdoctoral Scholar, Psychiatry
BioChunyang Dong completed his Ph.D. studies from University of California, Davis with Dr. Lin Tian, where he specialized in protein engineering to develop genetically encoded biosensors to enable real-time imaging of neuromodulator dynamics. As part of his postdoctoral pursuits with Dr. Sergiu Pasca at Stanford University, he hopes to combine disciplines between biosensors and modeling human neurological disease using brain region-specific organoids. Despite this shift, his unwavering goal is to deepen the understanding of brain development, disease processes, and translate research to potential treatments for neurological disorders.
-
Fei Dong
Associate Professor of Pathology
BioDr. Dong is the Director of Molecular Pathology at Stanford Health Care. The Molecular Pathology laboratory offers a broad menu of clinical diagnostic tests ranging from PCR to next generation sequencing. Dr. Dong's academic interests include the clinical implementation of laboratory developed tests, the development of novel informatics algorithms, and characterization of disease by molecular methods. Before arriving at Stanford, Dr. Dong was on faculty at Brigham and Women’s Hospital/Harvard Medical School for nine years, where he established a track record in education and mentorship and was the recipient of both the Anatomic Pathology and Clinical Pathology resident teaching awards. Dr. Dong has served on committees for the Association for Molecular Pathology, the Clinical and Laboratory Standards Institute, and the United States and Canadian Academy of Pathology. He serves on the editorial boards of multiple scientific journals and is an Associate Editor for the Journal of Molecular Diagnostics.
